Cost-effectiveness analyses of treatments for multiple sclerosis: are they clinically relevant?
- PMID: 21775745
- DOI: 10.1212/WNL.0b013e318227066d
Cost-effectiveness analyses of treatments for multiple sclerosis: are they clinically relevant?
Comment on
-
Cost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based study.Neurology. 2011 Jul 26;77(4):355-63. doi: 10.1212/WNL.0b013e3182270402. Epub 2011 Jul 20. Neurology. 2011. PMID: 21775734 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical